Goeltz II Robert C.

Officer at RCUS; Chief Financial Officer at CTMX

Sold, on record
$1.6M
Dollars the filings state
Form 4 sales
11
Latest May 11, 2026
Form 144 notices
9
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • RCUSArcus Biosciences, Inc.Officer
  • CTMXCytomX Therapeutics, Inc.Chief Financial Officer

Sales by reason

3
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 144 notice RCUSNotice
    Nov 26, 2025 2025

    Filed to sell 5,000 shares ($125k)

    Goeltz II Robert C., Officer

    10b5-1 plan1.4x usual sizeFiling

  2. 2 Form 4 sale RCUSRoutine
    Nov 26, 2025 same day

    Sold 5,000 shares at $25.00 ($125k)

    Goeltz II Robert C., Chief Financial Officer

    10b5-1 planSold 5.4% of holdings ($2.3M position)87,138 shares left1.4x usual sizeFollows a Form 144Filing

  3. 3 Form 144 notice RCUSNotice
    Dec 15, 2025 +19 days

    Filed to sell 14,000 shares ($307k)

    Goeltz II Robert C., Officer

    10b5-1 plan3.3x usual sizeFiling

  4. 4 Form 4 sale RCUSRoutine
    Dec 17, 2025 +2 days

    Sold 12,662 shares at $22.01 ($279k)

    Goeltz II Robert C., Chief Financial Officer

    10b5-1 planSold 14.5% of holdings ($1.9M position)74,476 shares left2.9x usual sizeFollows a Form 144Filing

  5. 5 Form 144 notice RCUSNotice
    Dec 31, 2025 +14 days

    Filed to sell 6,552 shares ($153k)

    Goeltz II Robert C., Officer

    10b5-1 plan1.3x usual sizeFiling

  6. 6 Form 4 sale RCUSRoutine
    Dec 31, 2025 same day

    Sold 6,552 shares at $23.38 ($153k)

    Goeltz II Robert C., Chief Financial Officer

    10b5-1 planSold 8.8% of holdings ($1.7M position)67,924 shares left1.3x usual sizeFollows a Form 144Filing

  7. 7 Form 144 notice RCUSNotice
    May 11, 2026 +131 days

    Filed to sell 7,763 shares ($199k)

    Goeltz II Robert C., Officer

    10b5-1 plan1.6x usual sizeFiling

  8. 8 Form 4 sale RCUSRoutine
    May 11, 2026 same day

    Sold 7,763 shares at $25.63 ($199k)

    Goeltz II Robert C., Chief Financial Officer

    10b5-1 planSold 8.4% of holdings ($2.4M position)84,161 shares left1.6x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (20)

Form 144 notices and Form 4 sales by Goeltz II Robert C.
Source
May 11, 2026May 12, 2026RCUSChief Financial OfficerForm 4 sale7,763$199k8.4%RoutineSEC
May 11, 2026May 11, 2026RCUSOfficerForm 144 notice7,763$199kNoticeSEC
Dec 31, 2025Jan 2, 2026RCUSChief Financial OfficerForm 4 sale6,552$153k8.8%RoutineSEC
Dec 31, 2025Dec 31, 2025RCUSOfficerForm 144 notice6,552$153kNoticeSEC
Dec 17, 2025Dec 18, 2025RCUSChief Financial OfficerForm 4 sale12,662$279k14.5%RoutineSEC
Dec 15, 2025Dec 15, 2025RCUSOfficerForm 144 notice14,000$307kNoticeSEC
Nov 26, 2025Nov 26, 2025RCUSChief Financial OfficerForm 4 sale5,000$125k5.4%RoutineSEC
Nov 26, 2025Nov 26, 2025RCUSOfficerForm 144 notice5,000$125kNoticeSEC
Oct 28, 2025Oct 29, 2025RCUSChief Financial OfficerForm 4 sale5,000$100k5.1%RoutineSEC
Oct 28, 2025Oct 28, 2025RCUSOfficerForm 144 notice5,000$100kNoticeSEC
Dec 31, 2024Jan 3, 2025RCUSChief Financial OfficerForm 4 sale3,594$54k5.6%RoutineSEC
Dec 31, 2024Dec 31, 2024RCUSOfficerForm 144 notice3,594$54kNoticeSEC
Jan 2, 2024Jan 4, 2024RCUSChief Financial OfficerForm 4 sale2,004$40k3.7%RoutineSEC
Jan 2, 2024Jan 2, 2024RCUSOfficerForm 144 notice2,004$40kNoticeSEC
Dec 15, 2023Dec 15, 2023RCUSOfficerForm 144 notice5,500$96kNoticeSEC
Jun 7, 2023Jun 9, 2023RCUSChief Financial OfficerForm 4 sale4,049$81k6.4%RoutineSEC
Jun 7, 2023Jun 7, 2023RCUSOfficerForm 144 notice4,049$81kNoticeSEC
Dec 16, 2022Dec 16, 2022RCUSChief Financial OfficerForm 4 sale2,453$75k17.5%Plan not statedSEC
Dec 17, 2021Dec 20, 2021RCUSChief Financial OfficerForm 4 sale1,106$44k13.6%Plan not statedSEC
Mar 20, 2017Mar 21, 2017CTMXChief Financial OfficerForm 4 sale21,517$426k68.7%UnusualSEC